indalotherapeutics.comIndalo Therapeutics | Innovative Approaches to the Treatment of Fibrotic Disease

indalotherapeutics.com Profile

indalotherapeutics.com

Title:Indalo Therapeutics | Innovative Approaches to the Treatment of Fibrotic Disease

Description:Indalo Therapeutics is a preclinical-stage biotechnology company dedicated to translating groundbreaking scientific discoveries into novel therapies for fibrotic diseases

Discover indalotherapeutics.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site

indalotherapeutics.com Information

Website / Domain: indalotherapeutics.com
HomePage size:23.872 KB
Page Load Time:0.379467 Seconds
Website IP Address: 50.116.42.122
Isp Server: Linode LLC

indalotherapeutics.com Ip Information

Ip Country: United States
City Name: Pomona
Latitude: 39.42008972168
Longitude: -74.499839782715

indalotherapeutics.com Keywords accounting

Keyword Count

indalotherapeutics.com Httpheader

X-FW-Static: NO
Content-Length: 6327
X-FW-Serve: TRUE
X-Cache: HIT
Content-Encoding: gzip
X-FW-Type: VISIT
Accept-Ranges: bytes
Vary: Accept-Encoding
X-Cacheable: YES
Server: Flywheel/4.1.0
X-FW-Hash: mmy43crmwn
Connection: keep-alive
Link: ; rel="https://api.w.org/", ; rel=shortlink
X-Hits: 1
Date: Wed, 04 Apr 2018 04:19:02 GMT
Content-Type: text/html; charset=UTF-8

indalotherapeutics.com Meta Info

50.116.42.122 Domains

Domain WebSite Title
disabilityresearchcenter.comDisability Research Center — Research, Fellowships and
rivervest.comRiverVest Venture Partners - Investing in Life Science
disabilityresearchcenter.comRFA-2018-03 Developmental Monitoring and Language
langhornere.comLanghorne | Re
accuronix.comAccuronix – Developing novel cancer therapies
aahd.usAAHD Scholarship Program
pulsetherapeutics.comTeam | Pulse Therapeutics
aahd.usAmerican Samoa: Emergency Preparedness Resources

indalotherapeutics.com Similar Website

Domain WebSite Title

indalotherapeutics.com Traffic Sources Chart

indalotherapeutics.com Alexa Rank History Chart

indalotherapeutics.com aleax

indalotherapeutics.com Html To Plain Text

Indalo Therapeutics | Innovative Approaches to the Treatment of Fibrotic DiseaseHomeAbout UsGroundbreaking ScienceCutting-Edge TechnologyTransforming LivesTeamManagementBoard of DirectorsAdvisorsNewsPublicationsContact UsInnovative Approaches to the Treatment of Fibrotic Disease Innovative Approaches to the Treatment of Fibrotic DiseaseGroundbreaking Science Attacking a fundamental mechanism central to fibrosis Cutting-Edge Technology Developing small-molecule antagonists of integrin proteins Transforming Lives Creating therapies for patients suffering from debilitating diseases Indalo Named Top 20 Startup by BioSpaceNextGen Class of 2018 Recognizes “Stellar” Life Sciences Companies Indalo has been named one of the “top 20 life sciences startups to watch in 2018” by BioSpace. The industry news and information service presented its NextGen Class of 2018 in January to highlight “a stellar group of companies that are already making an enormous impact”… Read More »»Murray IR, et al. 2017Murray IR, et al. αv integrins on mesenchymal cells regulate skeletal and cardiac muscle fibrosis. Nat Commun. 2017 Oct 24;8(1):1118. Abstract Mesenchymal cells expressing platelet-derived growth factor receptor beta (PDGFRβ) are known to be important in fibrosis of organs such as the liver and kidney. Here we show that PDGFRβ+ cells contribute to skeletal muscle and… Read More »»Committed to InnovationIndalo Therapeutics is a preclinical-stage biotechnology company dedicated to translating groundbreaking scientific discoveries into novel therapies for fibrotic diseases. Our approach is based on cutting-edge research elucidating the central role played by integrin proteins in aberrant fibrotic responses. The company’s lead program is focused on an oral treatment for solid organ fibrosis, which encompasses an array of progressive and debilitating conditions that currently have few FDA-approved medications.Committed to PatientsFibrotic diseases collectively afflict millions of people around the world and are characterized by high rates of morbidity and mortality. These patients are Indalo’s inspiration, and our mission is to improve their lives by developing therapies that arrest or reverse their fibrosis. Our team includes veteran executives who have experienced firsthand the satisfaction of bringing hope to patients suffering from chronic fibrotic diseases through the successful development and approval of an innovative drug for pulmonary fibrosis.More InformationIndalo Therapeutics, Inc.4320 Forest Park Ave., Ste. 304St. Louis, MO 63108Contact UsCopyright © 2018 Indalo Therapeutics, Inc. · All Rights Reserved · Powered by NeuConcept Productions'); document.write('');}...

indalotherapeutics.com Whois

"updated_date": [ "2017-09-13 08:34:09", "2017-09-13T01:34:09.00Z" ], "status": [ "clientTransferProhibited https://icann.org/epp#clientTransferProhibited", "clientTransferProhibited https://www.icann.org/epp#clientTransferProhibited" ], "name": "JUDY BALLARD", "dnssec": [ "unsigned", "unSigned" ], "city": "ST. LOUIS", "expiration_date": [ "2018-10-12 21:52:38", "2018-10-12T21:52:00.00Z" ], "zipcode": "63108", "domain_name": "INDALOTHERAPEUTICS.COM", "country": "US", "whois_server": "whois.enom.com", "state": "MO", "registrar": "ENOM, INC.", "referral_url": null, "address": "20 S. SARAH", "name_servers": [ "DNS1.NAME-SERVICES.COM", "DNS2.NAME-SERVICES.COM", "DNS3.NAME-SERVICES.COM", "DNS4.NAME-SERVICES.COM", "DNS5.NAME-SERVICES.COM" ], "org": "RIGHT ON SITE ADMINISTRATIVE SOLUTIONS, LLC", "creation_date": [ "2016-10-12 21:52:38", "2016-10-12T21:52:38.00Z" ], "emails": [ "REG@NEUCONCEPT.COM", "abuse@enom.com" ]